China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
1.020
+0.030 (3.03%)
Apr 19, 2024, 4:00 PM EDT - Market closed

China SXT Pharmaceuticals Revenue

China SXT Pharmaceuticals had revenue of $29.92K in the twelve months ending September 30, 2023. In the fiscal year ending March 31, 2023, China SXT Pharmaceuticals had annual revenue of $33.62K, a decrease of -90.09%.

Revenue (ttm)
$29.92K
Revenue Growth
-90.09%
P/S Ratio
356.13
Revenue / Employee
$384
Employees
78
Market Cap
10.66M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202333.62K-305.51K-90.09%
Mar 31, 2022339.13K-545.86K-61.68%
Mar 31, 2021884.99K554.56K167.83%
Mar 31, 2020330.43K118.28K55.75%
Mar 31, 2019212.16K-1.10M-83.89%
Mar 31, 20181.32M585.53K80.04%
Mar 31, 2017731.51K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Guardion Health Sciences 12.25M
Can-Fite BioPharma 743.00K
Organovo Holdings 242.00K
ABVC BioPharma 152.43K
Nexalin Technology 110.75K
Bionomics 15.00K
Revenue Rankings